Glenmede Trust CO Na Embecta Corp. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.87 - $19.09 $5,057 - $7,502	393 Added 3.35%	12,115 $229,000
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $3,750 - $5,542	-250 Reduced 2.09%	11,722 $176,000
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $8,005 - $11,371	347 Added 2.98%	11,972 $336,000
Q4 2022 Feb 14, 2023	SELL	$25.29 - $35.48 $41,450 - $58,151	-1,639 Reduced 12.36%	11,625 $293,000
Q3 2022 Nov 16, 2022	SELL	$24.0 - $33.42 $3,648 - $5,079	-152 Reduced 1.13%	13,264 $380,000

Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $332,448 - $447,557	13,416 New	13,416 $338,000

392

52.2M

45.7K

49K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $723M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.